News about Biotechnology

ICMR to present fully indigenous diagnostic platform for COVID-19

The Indian Council of Medical Research (ICMR) has validated a fully indigenous diagnostic platform for COVID-19 diagnosis.

Biotechnology | 25/05/2020 | By Darshana |  264

FDA Provides Promised Transparency for Antibody Tests

Today, the U.S. Food and Drug Administration posted a list of antibody tests that are being removed from the notification list of tests being offered under the Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency

Biotechnology | 22/05/2020 | By Darshana |  169

BELLUS Health Convenes Virtual KOL Meeting to Discuss the State of Chronic Cough Treatment

Bellus a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced that it will convene a virtual Key Opinion Leader (KOL) meeting to discuss the chronic cough landscape on Wednesday, May 27, 2020 at 9:00 a.m. EDT

Biotechnology | 15/05/2020 | By Darshana |  324

ICMR notifies NIMHANS as mentor institution for RT-PCR test protocol for COVID-19

The National Institute of Mental Health and Neuro Sciences (NIMHANS) has been notified by the Indian Council of Medical Research (ICMR) and the Medical Council of India (MCI) as the mentor institution for RT-PCR (Reverse transcription-polymerase chain reaction) test

Biotechnology | 10/05/2020 | By Darshana |  316

Hydroxychloroquine and Chloroquine Marketto more than Double in 2020 ? TechSci Research

Increase in prevalence of COVID-19 to drive demand for hydroxychloroquine and chloroquine across the globe

Biotechnology | 29/04/2020 | By Darshana |  177

Alembic Pharma gets US FDA approval for Lastacaft ophthalmic solution

Alembic Pharmaceuticals Limited has received tentative approval from the US Food & Drug Administration (FDA) for its abbreviated new drug application (ANDA) alcaftadine ophthalmic solution, 0.25%

Biotechnology | 21/04/2020 | By Darshana |  744

Oncolytics Biotech updates clinical development & operations activities during COVID-19 pandemic

Oncolytics Biotech Inc., currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, provided an update on the potential impact of COVID-19 on the company's clinical and business operations

Biotechnology | 20/04/2020 | By Darshana |  291

FDA Encourages Recovered Patients to Donate Plasma for Development of Blood-Related Therapies

As part of the all-of-America approach to fighting the COVID-19 pandemic, the U.S. Food and Drug Administration has been working with partners across the U.S. government, academia and industry to expedite the development and availability of critical medical products to treat this novel virus

Biotechnology | 19/04/2020 | By Darshana |  270

Abbott Launches Molecular Point-Of-Care Test, ID NOW COVID-19 Tests to Detect Coronavirus in as Little as 5 Minutes

Abbott announced that the US Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes

Biotechnology | 30/03/2020 | By Darshana |  993

Mylab Ships First Batch of COVID 19 Test Kits To Government And Private Labs

First batch of Made in India Testing kit for Covid-19 to be shipped today, Government and private labs approved by ICMR to conduct tests. Mylab can ramp-up capacity from 20,000 to 50,000 kits a day if needed

Biotechnology | 27/03/2020 | By Darshana |  633